日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Quantitative comparison of the mRNA content of human iPSC-derived motor neurons and their extracellular vesicles.

人类 iPSC 衍生运动神经元及其细胞外囊泡的 mRNA 含量定量比较

Otake Kentaro, Adachi-Tominari Keiko, Nagai Hiroaki, Saito Masayo, Sano Osamu, Hirozane Yoshihiko, Iwata Hidehisa

A Cell-Based High-Throughput Screening Identified Two Compounds that Enhance PINK1-Parkin Signaling

基于细胞的高通量筛选鉴定出两种可增强PINK1-Parkin信号传导的化合物

Shiba-Fukushima, Kahori; Inoshita, Tsuyoshi; Sano, Osamu; Iwata, Hidehisa; Ishikawa, Kei-Ichi; Okano, Hideyuki; Akamatsu, Wado; Imai, Yuzuru; Hattori, Nobutaka

Anti-angiogenic and anti-tumor effects of TAK-593, a potent and selective inhibitor of vascular endothelial growth factor and platelet-derived growth factor receptor tyrosine kinase.

TAK-593 是一种强效且选择性的血管内皮生长因子和血小板衍生生长因子受体酪氨酸激酶抑制剂,具有抗血管生成和抗肿瘤作用

Awazu Yoshiko, Mizutani Akio, Nagase Yoshinori, Tsuchiya Shuntarou, Nakamura Kazuhide, Kakoi Yuichi, Kitahara Osamu, Takeuchi Toshiyuki, Yamasaki Seiji, Miyamoto Naoki, Iwata Hidehisa, Miki Hiroshi, Imamura Shinichi, Hori Akira

A novel pyrrolo[3, 2-d]pyrimidine derivative, as a vascular endothelial growth factor receptor and platelet-derived growth factor receptor tyrosine kinase inhibitor, shows potent antitumor activity by suppression of tumor angiogenesis.

一种新型吡咯并[3, 2-d]嘧啶衍生物,作为血管内皮生长因子受体和血小板衍生生长因子受体酪氨酸激酶抑制剂,通过抑制肿瘤血管生成显示出强大的抗肿瘤活性

Awazu Yoshiko, Mizutani Akio, Nagase Yoshinori, Iwata Hidehisa, Oguro Yuya, Miki Hiroshi, Imamura Shinichi, Hori Akira